Increased prevalence of transglutaminase 6 antibodies in sera from schizophrenia patients

Schizophrenia Bulletin

Volumn 39, Issue 4, 2013, Pages 867-871

  Cascella, Nicola G ^a   Santora, Debby ^b   Gregory, Patricia ^c   Kelly, Deanna L ^b   Fasano, Alessio ^b   Eaton, William W ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

celiac disease; gluten sensitivity; gluten free diet; schizophrenia; transglutaminase 6

Indexed keywords

GLIADIN ANTIBODY; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSGLUTAMINASE 6; UNCLASSIFIED DRUG;

ADULT; AGE; ANTIBODY BLOOD LEVEL; ARTICLE; ATAXIA; CONTROLLED STUDY; FEMALE; GLUTEN FREE DIET; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE;

EID: 84879384060     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs064     Document Type: Article

References (20)

1. Hadjivassiliou M, Sanders DS, Grunewald RA, Woodroofe N, Boscolo S, Aeschlimann D. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010; 9: 318-330.
2. Fry L. Dermatitis herpetiformis. Baillieres Clin Gastroenterol. 1995; 9: 371-393.
3. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet. 1998; 352: 1582-1585. (Pubitemid 28515242)
4. Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002; 195: 747-757. (Pubitemid 34259719)
5. Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol. 2008; 64: 332-343.
6. Aeschliman D. Novel transglutaminase gene products. U S Patent 7. 2006: 052, 890.
7. Cascella NG, Kryszak D, Bhatti B, et al. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr Bull. 2011; 37: 94-100.
8. Dickerson F, Stallings C, Origoni A, et al. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry. 2010; 68: 100-104.
9. Clemente MG, Musu MP, Frau F, Lucia C, De Virgiliis S. Antitissue transglutaminase antibodies outside celiac disease. J Pediatr Gastroenterol Nutr. 2002; 34: 31-34. (Pubitemid 34251698)
10. Catassi C, Kryszak D, Louis-Jacques O, et al. Detection of celiac disease in primary care: a multicenter case-finding study in north america. Am J Gastroenterol. 2007; 102: 1454-1460. (Pubitemid 46976276)
11. Sapone A, Lammers KM, Casolaro V, et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med. 2011; 9: 23.
12. Yang Y, Wan C, Li H, Zhu H, et al. Altered levels of acute phase proteins in the plasma of patients with schizophrenia. Anal Chem. 2006; 78: 3571-3576. (Pubitemid 43848947)
13. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011; 91: 151-175.
14. Lu R, Wang W, Uzzau S, Vigorito R, Zielke HR, Fasano A. Affinity purification and partial characterization of the zonulin/zonula occludens toxin (zot) receptor from human brain. J Neurochem. 2000; 74: 320-326. (Pubitemid 30012784)
15. Tripathi A, Lammers KM, Goldblum S, et al. Fasano AIdentification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A. 2009; 106: 16799-16804.
16. Karyekar CS, Fasano A, Raje S, Lu R, Dowling TC, Eddington ND. Zonula occludens toxin increases the permeability of molecular weight markers and chemotherapeutic agents across the bovine brain microvessel endothelial cells. J Pharm Sci. 2003; 92: 414-423. (Pubitemid 36169314)
17. Schrodl D, Kahlenberg F, Peter-Zimmer K, HermannW, Kuhn HJ, Mothes T. Intrathecal synthesis of autoantibodies against tissue transglutaminase. J Autoimmun. 2004; 22: 335-340. (Pubitemid 38543225)
18. Kivisakk P, Tucky B, Wei T, Campbell JJ, Ransohoff RM. Human cerebrospinal fluid contains CD4+ memory T cells expressing gut- or skin-specific trafficking determinants: relevance for immunotherapy. BMC Immunol. 2006; 7: 14.
19. Kaladjan AE, Eaton W, Cascella N, Fasano A. The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand. 2006; 113: 82-90. (Pubitemid 43340901)
20. Eaton WW, Byrne M, Ewald H, et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006; 163: 521-528. (Pubitemid 44469397)